Novo Nordisk challenges Pfizer's $47.50 per share deal for Metsera with a $6.5B bid, offering $56.50 per share in cash up front plus potential milestones.
Cracker Barrel's controversial rebrand sparks backlash and a viral AI-generated joke about the White House, leading to the company's self-aware response and a case study in corporate PR recovery.
College football's coaching carousel sees high-profile vacancies amid political and diversity challenges.
Novo Nordisk challenges Pfizer's $47.50 per share deal for Metsera with a $6.5B bid, offering $56.50 per share in cash up front plus potential milestones.
Cracker Barrel's controversial rebrand sparks backlash and a viral AI-generated joke about the White House, leading to the company's self-aware response and a case study in corporate PR recovery.
College football's coaching carousel sees high-profile vacancies amid political and diversity challenges.